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Introduction: Human missions to Mars will 
fundamentally transform how the planet is explored, 
enabling new scientific discoveries through more 
sophisticated sample acquisition and processing than 
can currently be implemented in robotic exploration. 
The presence of humans also poses new challenges, 
including ensuring astronaut safety and health and 
monitoring contamination. Because the capability to 
transfer materials to Earth will be extremely limited, 
there is a strong need for in situ diagnostic capabilities.  
Nucleotide sequencing is a particularly powerful 
tool because it can be used to: (1) mitigate microbial 
risks to crew by allowing identification of microbes in 
water, in air, and on surfaces; (2) identify optimal 
treatment strategies for infections that arise in crew 
members; and (3) track how crew members, microbes, 
and mission-relevant organisms (e.g., farmed plants) 
respond to conditions on Mars though transcriptomic 
and genomic changes. Sequencing would also offer 
benefits for science investigations occurring on the 
surface of Mars by permitting identification of Earth-
derived contamination in samples. If Mars contains 
indigenous life, and that life is based on nucleic acids or 
other closely related molecules, sequencing would serve 
as a critical tool for the characterization of those 
molecules. Therefore, spaceflight-compatible nucleic 
acid sequencing would be an important capability for 
both crew health and astrobiology exploration.   
 
 
Figure 1. Nanopore-based sequencers measure changes in 
current caused by DNA strands passing through the pore. 
The changes in current are diagnostic of the sequence of 
DNA passing through the pore.  
Advances in sequencing technology on Earth have 
been driven largely by needs for higher throughput and 
read accuracy. Although some reduction in size has 
been achieved, nearly all commercially available 
sequencers are not compatible with spaceflight due to 
size, power, and operational requirements. Exceptions 
are nanopore-based sequencers that measure changes in 
current caused by DNA passing through pores; these 
devices are inherently much smaller and require 
significantly less power than sequencers using other 
detection methods. Consequently, nanopore-based 
sequencers could be made flight-ready with only 
minimal modifications.  
 
  
Biomolecule Sequencer Project: As a first step 
towards evaluating the suitability of nanopore-based 
sequencing as a tool for human exploration, the 
Biomolecule Sequencer project [1] will test the 
commercially available MinIONTM device (Oxford 
Nanopore Technologies) aboard the International Space 
Station (Figure 2). The initial flight test of the 
MinIONTM will evaluate how the device performs after 
 
Figure 2. The MinIONTM device (circled) sits atop the 
Illumina MiSeq sequencer. The MinIONTM device  is a 
nanopore sequencer that weighs less than 150 g, and occupies 
a volume of less than 100 cm3. 
flight to the ISS and under continuous microgravity 
conditions. The samples to be sequenced, containing 
lambda bacteriophage, Escherichia coli and mouse 
genomic DNA, will be prepared for sequencing on the 
ground and stored frozen until they are analyzed in-
flight in parallel with ground control samples. 
Immediately prior to sequencing, the crew member will 
thaw a frozen sample, inject the thawed sample into a 
new flow cell, and initiate sequencing. After ~5 GB of 
sequence data have been acquired, sequencing will be 
terminated and the data downlinked to Earth for 
analysis. The concept of operations, from sample 
preparation to termination of sequencing, was 
successfully tested aboard a parabolic flight [2]. 
Certification of the flight hardware is expected to be 
completed by the end of March 2016. The Biomolecule 
Sequencer payload is expected to be launched in June 
2016, and in-flight testing is expected to be completed 
by the end of 2016. Should in-flight sequencing prove 
feasible, the next milestone will be demonstrating end-
to-end in-flight sequencing, from sample collection to 
data analysis. 
 
Sequencing as a tool for astrobiology: Nucleic 
acid sequencing is well-known as a versatile tool for 
Astrobiology. Sequencing can place extremophiles in 
evolutionary context [e.g., 3-5], provide insights into the 
origin and evolution of the ribosome itself [e.g., 6, 7], 
and give key information regarding organismal 
metabolism [e.g., 8]. Sequence data have been 
successfully obtained from samples including: DNA 
from bones that were hundreds of thousands of years old 
[9,10]; insects trapped in amber over 100 million years 
old [11]; and archaea entrained in halite crystals over 
400 million years old [12]. This remarkable 
preservation potential for DNA coupled with the 
amount of organismal information that can be obtained 
from even partial genomic sequences, provides strong 
support for the inclusion of nucleic acid sequencing as 
an important component of a life detection mission.  
However, a major limitation of traditional DNA or 
RNA sequencing methods for life detection elsewhere 
in the solar system is that they can sequence only DNA 
or RNA. If life existed elsewhere but used informational 
molecules other than DNA or RNA, conventional 
sequencers would not be able to obtain sequence data, 
even from closely related nucleic acid analogs such as 
arabinose or threose nucleic acids (Figure 3). Because 
nanopore based sequencers such as the the MinIONTM 
measure changes in current based on the polymer 
passing through them, they can also read RNA, proteins, 
and other polymers as well [13]. Thus, nanopore-based 
sequencing provides much greater versatility as a life 
detection tool than would sequencers that require 
nucleic acid synthesis or other detection methods.  
 
 
Figure 3. Examples of nucleic acid-like molecules that 
could support life. Nanopore-based sequencers have the 
potential to detect these kinds of molecules, whereas 
sequencers that require synthesis or incorporation of 
chromophores would not. 
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